GORDON, K.; FOLEY, P.; KRUEGER, J.; PINTER, A.; REICH, K.; VENDER, R.; VANVOORDEN, V.; MADDEN, C.; PETERSON, L.; BLAUVELT, A. Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE READY, a 56-Week Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study with Randomized Withdrawal. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s83, 2020. DOI: 10.25251/skin.4.supp.83. DisponĂ­vel em: https://www.jofskin.org/index.php/skin/article/view/1116. Acesso em: 17 may. 2022.